Susquehanna Upgrades Tenet Healthcare (THC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/25/2026
- US stock futures rise on tech rebound before Nvidia, inflation tests
- Oil hits one-week low as investors shrug off US sanctions on Iran
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- Wattmore and Eos Energy strike non-exclusive storage software deal
- Grand Canyon Education places CFO on leave amid stock trade probe
- S&P 500, Nasdaq end down on tech stocks, investors weigh Iran moves
- Funds sell $44bn in semiconductors on AI concerns
- RUM Group signs $13.7 billion GPU services deal, issues warrants
Raymond James Upgrades Tenet Healthcare (THC) to Outperform
August 6, 2014 7:26 AM EDTRaymond James upgraded Tenet Healthcare (NYSE: THC) from Market Perform to Outperform with a price target of $65.00.
For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.
Shares of Tenet Healthcare closed at $54.83 yesterday.
... MoreTenet Healthcare Corp. (THC) Posts Q2 Loss of 27c/Share; Boosts FY14 adj.-EBITDA Outlook
August 4, 2014 4:16 PM EDTTenet Healthcare Corp. (NYSE: THC) reported Q2 EPS of ($0.27), which may not compare with the analyst estimate of $0.01. Revenue for the quarter came in at $4.04 billion versus the consensus estimate of $3.94 billion.
The second quarter of 2014 included a $92 million increase in pre-tax interest... More
